The 2026 Medicare Physician Fee Schedule (MPFS) RVU adjustments are directly reducing per-encounter neurology reimbursement — with the budget-neutrality conversion factor cut translating to $8 to $22 in lost revenue per high-complexity office visit and compounding into $90,000 to $240,000 in per-physician annual shortfall for practices that have not restructured their Revenue Cycle Management (RCM) strategy in response.
For neurology practices operating on Medicare-heavy patient panels, the 2026 MPFS is not a regulatory footnote — it is a margin compression mechanism that affects every billable encounter from a Level 4 E/M visit to a nerve conduction study interpretation. Understanding exactly which CPT codes lost value, why the RVU reduction is structurally permanent, and what billing infrastructure changes can protect net realized revenue growth is the difference between a practice that stabilizes margins and one that absorbs the loss silently, quarter after quarter.
For a foundational review of how RVU-based reimbursement affects neurology coding at the encounter level, see Understanding Basics of Neurology Billing for Improved Payments.
What Are the 2026 Medicare RVU Adjustments — and Why Do They Hit Neurology Disproportionately?
The Medicare conversion factor — the dollar multiplier applied to every RVU assigned to a CPT code — was reduced in the 2026 MPFS final rule as part of the budget-neutrality requirement embedded in the Balanced Budget Act of 1997. When CMS increases RVU values for certain service categories (in 2026, primary care E/M codes received targeted increases), the overall conversion factor must be adjusted downward to keep total Medicare spending neutral.
For neurology, this creates a compounding loss: the specialty did not receive the proportional E/M value increases allocated to primary care, yet it absorbs the same conversion factor reduction applied uniformly across all specialties. The result is a net reimbursement reduction on the highest-volume CPT codes in a neurology practice’s billing mix — precisely the codes that constitute the majority of Medicare revenue.
The 2026 MPFS conversion factor decreased to approximately $32.35 per RVU from the prior year’s rate, representing a reduction that erodes reimbursement on every neurology encounter billed to Medicare and Medicare Advantage plans that use MPFS as their fee schedule basis.
How Much Is Your Neurology Practice Losing Per Physician?
The following model quantifies the 2026 MPFS impact for a neurology practice billing 400 to 600 Medicare encounters per month per physician — a volume consistent with a multi-condition neurologist managing an established Medicare patient panel:
| Revenue Category | Monthly Volume | Per-Encounter Loss | Per-12-Months Revenue Reduction |
|---|---|---|---|
| High-complexity E/M (99214–99215) | 280–380 encounters | $6–$12 | $20,160–$54,720 |
| EEG interpretations (95812–95813) | 30–60 studies | $7–$11 | $2,520–$7,920 |
| Nerve conduction studies (95907–95913) | 40–80 studies | $6–$14 | $2,880–$13,440 |
| EMG studies (95860–95872) | 20–40 studies | $4–$6 | $960–$2,880 |
| CCM / Cognitive assessment codes | 15–30 encounters | $3–$8 | $540–$2,880 |
| Total per-physician impact | $27,060–$81,840 |
For a four-physician neurology group, the 2026 MPFS conversion factor reduction represents $108,240 to $327,360 in per-12-months revenue reduction — with no claim denials, no coding errors, and no operational failures involved. This is pure fee schedule compression.
The practices absorbing this loss without a countermeasure are those relying on Medical Billing Services that benchmark performance against prior-year collections rather than current MPFS rates — and that do not have payer variance detection infrastructure identifying which Medicare Advantage plans have not yet adopted the 2026 MPFS conversion factor update in their own fee schedules.
For a comprehensive review of how CPT and ICD-10 coding accuracy intersects with neurodiagnostic reimbursement, see Understanding CPT and ICD-10 Codes for Neurology Billing.
The Medicare Advantage Divergence: Where Payer Variance Detection Becomes Critical
The 2026 MPFS conversion factor applies directly to traditional Medicare fee-for-service claims. Medicare Advantage (MA) plans, which now cover more than 50% of Medicare-eligible beneficiaries in most neurology practice markets, are not required to update their fee schedules on the same timeline. This creates a payer variance detection opportunity that most neurology practices are not systematically capturing.
In the 60 to 180 days following a MPFS conversion factor adjustment, a measurable percentage of MA plans continue paying neurology claims at rates derived from the prior-year conversion factor — either because their internal fee schedule update cycle lags, because their contracts reference MPFS without specifying a calendar year update trigger, or because automated repricing engines have not yet loaded the current rate table.
Practices with active payer variance monitoring identify these discrepancies and continue receiving the higher legacy rate through targeted claims tracking. Practices without this infrastructure simply receive whatever the MA plan’s system pays — and never know the difference.
Three Revenue Recovery Strategies That Offset the 2026 RVU Reduction
Strategy 1 — E/M Level Optimization Through MDM-Based Documentation
The AMA’s 2021 E/M revision shifted the basis for E/M level selection from time-plus-examination to Medical Decision Making (MDM) complexity. For neurology, this revision created a systematic opportunity to bill Level 5 (99215) for encounters that, under the prior exam-based framework, were frequently coded at Level 4 (99214) due to documentation structure rather than clinical complexity.
The neurology encounter that addresses epilepsy with medication adjustment, evaluates a new cognitive complaint, reviews a recent MRI, and manages co-existing hypertension meets the high-complexity MDM threshold for 99215 — provided the documentation captures the number and complexity of problems, the amount and complexity of data reviewed, and the risk of complications. Practices with MDM-aligned documentation protocols capture an additional $18 to $28 per encounter on visits that would otherwise default to 99214, generating $36,000 to $100,800 per physician in per-12-months revenue recovery that partially offsets the conversion factor reduction.
Strategy 2 — Electrodiagnostic Add-On Code Capture
The most consistent source of Revenue Integrity loss in neurology electrodiagnostic billing is not the primary NCS or EMG code — it is the add-on codes that most practices systematically under-report because charge capture workflows are not configured to prompt for them.
Key add-ons with direct revenue recovery value:
- CPT 95885 / 95886 (Needle EMG add-on for limited/complete studies): Applicable when needle EMG is performed in conjunction with NCS — frequently omitted when billing teams are not trained to link the two service types at charge entry
- CPT 95938 (Short-latency somatosensory evoked potential): Reimbursable as a standalone interpretive service when documented separately from the primary electrodiagnostic study
- CPT 96020 (Neurofunctional testing): Applicable to neuropsychological testing sessions that include physician oversight — routinely under-billed by practices whose billing teams categorize all cognitive assessment under 99483
Consistent add-on code capture adds an estimated $40 to $90 per complete electrodiagnostic encounter — a recovery range that more than offsets the 2026 RVU reduction on the same procedure set.
Strategy 3 — Old AR Recovery on Pre-Conversion-Factor Claims
The 2026 MPFS adjustment creates a narrow Old AR Recovery window on neurology claims from 2024 and 2025 billing cycles that remain unpaid or underpaid in accounts receivable. Claims submitted under prior-year conversion factor rates that were denied, downcoded, or held by payer administrative review retain their original fee schedule basis — meaning that successful appeals recover revenue at the higher pre-2026 rate.
For neurology practices with AR Aging beyond 120 days on neurodiagnostic and high-complexity E/M claims, systematic Old AR Recovery work generates revenue at rates that are now effectively higher than current fee schedule rates on the same service types. This asymmetry is a concrete financial incentive to prioritize aged neurology AR before the appeal timely limit closes.
For more on how MBC approaches aged AR in high-complexity specialty practices, see Old AR Recovery Services.
Generic RCM vs. MBC’s Revenue Integrity Framework for Neurology
| Revenue Challenge | Generic RCM Vendor | In-House Billing Team | MBC’s Revenue Integrity Framework |
|---|---|---|---|
| 2026 MPFS conversion factor response | No payer rate update monitoring | Manual fee schedule comparison, monthly at best | Real-time payer variance detection across MA and commercial payers |
| E/M level optimization | MDM applied at generic complexity level | Provider-dependent, no systematic audit | MDM-aligned documentation review per encounter type before submission |
| Neurodiagnostic add-on capture | Add-ons billed when charge ticket includes them | Add-ons omitted when workflow has no prompt | Specialty-specific charge capture protocol with EEG/EMG/NCS add-on triggers |
| AR Aging on denied neurodiagnostic claims | Standard 90-day follow-up cycle | Internal team managing multiple priorities | Dedicated neurodiagnostic denial appeal track with LCD-specific rebuttal |
| Medicare Advantage variance tracking | Not monitored | Not available | Active MA plan rate tracking; overpayment and underpayment flagged per remittance |
| Net Collection Ratio result | 83–88% | 82–87% | 94–98% |
The revenue gap between a generic Medical Billing Company and a specialty-calibrated RCM Services partner is not primarily a function of denial management speed — it is a function of whether the billing infrastructure is built to capture what the fee schedule and payer contracts actually make available. For neurology in 2026, that distinction is worth $100,000 to $300,000 per physician in recoverable net realized revenue.
For billing guidelines and compliance resources specific to neurology coding, see Mastering 2024 Neurology Billing Guidelines for Reimbursement.
MBC Spotlight: Neurology Revenue Recovery in a 2026 MPFS Environment
MBC’s Neurology Billing Services are built on the operational infrastructure that the 2026 MPFS environment specifically demands — real-time payer rate monitoring, MDM-aligned E/M documentation review, specialty-coded neurodiagnostic add-on capture, and active Denial Management on LCD-governed electrodiagnostic claims.
Our dedicated account manager model assigns a neurology-trained billing specialist to every account who monitors your per-encounter E/M distribution monthly, benchmarks your neurodiagnostic procedure yield against specialty collection standards, and delivers Yield EBITDA reporting that quantifies the revenue difference between what your practice collected and what your fee schedule and payer contracts made available.
With MBC’s 97% clean claim rate across neurology encounter submissions, 30% A/R reduction within 90 days, and a system-agnostic platform that integrates with your existing EHR and practice management system, the 2026 MPFS conversion factor reduction becomes a margin protection challenge we solve at the billing infrastructure level — not a revenue loss you absorb at the practice level.
MBC’s Pricing Structure is percentage-based, with no hidden setup fees — aligned with collections, not claim volume — so our incentive is always to maximize what you collect, not to process the highest number of claims. For full details of MBC’s fee structure, see our Pricing page.
Practices that complete MBC’s Complimentary 90-Day AR Diagnostic consistently identify $80,000 to $220,000 in neurology revenue gaps tied specifically to RVU-level billing inefficiencies, missed add-on codes, and MA payer rate variance — gaps that the 2026 MPFS adjustment is widening, not creating.
Request Your Free Revenue Diagnostic
If your neurology practice’s Medicare collections are declining while patient volume holds steady, the 2026 RVU conversion factor is the structural cause — and the billing infrastructure response is what determines whether that loss is permanent or recoverable. Request Your Free Revenue Diagnostic and let MBC’s neurology billing specialists identify exactly where your per-encounter reimbursement is being compressed and what Revenue Cycle Management changes recover it before another quarter closes at a deficit. Contact us at info@medicalbillersandcoders.com or call 888-357-3226.
Frequently Asked Questions
The 2026 MPFS conversion factor decreased to approximately $32.35 per RVU, reducing neurology reimbursement by $5 to $22 per encounter, depending on CPT code, with the largest per-encounter impact falling on high-complexity E/M codes (99215) and multi-study nerve conduction evaluations (CPT 95913).
CPT 99214 and 99215 (high-complexity E/M), CPT 95812 and 95813 (EEG interpretations), CPT 95907 through 95913 (nerve conduction studies), and CPT 95860 through 95872 (EMG studies) all absorb the conversion factor reduction — collectively covering 70–85% of a typical neurology practice’s Medicare revenue volume.
No — Medicare Advantage plans update their fee schedules on their own cycles and are not required to adopt the 2026 MPFS conversion factor immediately, creating a payer variance window where some MA plans continue paying at prior-year rates, and others implement the reduction ahead of schedule, requiring active payer variance detection to identify underpayments and unexpectedly favorable rate windows.
The highest-yield response combines three strategies: MDM-based E/M documentation optimization to capture accurate Level 5 coding on complex multi-condition visits, systematic electrodiagnostic add-on code capture for CPT 95885, 95886, and 95938, and active Old AR Recovery on aged neurology claims from prior billing cycles where the higher pre-2026 conversion factor rate applies.
A specialty-calibrated Medical Billing Company with neurology-specific RCM Services recovers revenue the conversion factor reduction removes by capturing add-on codes that generic billing platforms miss, monitoring MA plan payer variance in real time, and applying MDM-aligned documentation review before claim submission — generating a Net Collection Ratio of 94–98% versus the 83–88% industry average that leaves $150,000 to $350,000 in recoverable revenue uncollected per billing cycle.
Catering to more than 40 specialties, Medical Billers and Coders (MBC) is proficient in handling services that range from revenue cycle management to ICD-10 testing solutions. The main goal of our organization is to assist physicians looking for billers and coders, at the same time help billing specialists looking for jobs, reach the right place.
